ST Genesia is an automated analyser, based on the same principles as the CAT system, which measures thrombin generation

Designed to support clinical, ST Genesia aims at standardising and automating the thrombin generation test in order to make it widely accessable and available for use in in-vitro diagnostics (IVD). 

ST Genesia is designed to add to the information usually provided by routine tests (TP, TCA, etc.) or specialised tests (Anti-Xa, ECA) and offer an improved assessment of thrombotic and haemorrhagic risks to improve patient care.

Click here to find out which biomarkers are available for testing on this platform.

You want to know if this technology may help you in your product development?

Discuss together to find the best solution for your product.

Contact us